Related Experiment Video
Updated: Mar 15, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Assessment of abdominal aortic calcification at different stages of chronic kidney disease
Zeynep Biyik1, Nedim Yilmaz Selcuk2, Halil Zeki Tonbul2
1Department of Nephrology, Konya Education and Researh Hospital, Meram, Konya, Turkey. drzeynepbiyik@gmail.com.
Insights
Abdominal aortic calcification (AAC) is common in chronic kidney disease (CKD) patients, especially those on hemodialysis. Managing phosphorus levels is crucial for reducing AAC in CKD patients.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Radiology
Background:
- Vascular calcifications are prevalent in chronic kidney disease (CKD) and increase cardiovascular disease risk.
- Abdominal aorta calcifications (AAC) are a significant marker of this risk.
Purpose of the Study:
- To determine AAC prevalence in predialysis and hemodialysis patients using lateral lumbar radiography.
- To identify factors associated with AAC in these patient groups.
Main Methods:
- Lateral lumbar radiography was used to assess AAC in 259 hemodialysis patients, 300 predialysis CKD patients, and 60 controls.
- A 24-point scoring system evaluated calcified deposits in the abdominal aorta.
Main Results:
- AAC prevalence was significantly higher in hemodialysis (71.8%) and predialysis (45.7%) CKD patients compared to controls (33.3%).
- Hemodialysis patients showed higher AAC scores than predialysis patients and controls.
- Independent predictors of AAC included age, diabetes mellitus, and serum phosphorus in hemodialysis patients; and age, serum phosphorus, and cardiovascular disease history in predialysis patients.
Conclusions:
- Abdominal aortic calcification is highly prevalent in hemodialysis patients.
- Strict phosphorus control is recommended for both predialysis and hemodialysis patients to mitigate AAC.
Purpose:
Vascular calcifications that may cause cardiovascular disease are highly prevalent in chronic kidney disease (CKD). In this study, we aimed to determine abdominal aorta calcifications (AAC) in predialysis and hemodialysis patients by lateral lumbar radiography and to investigate factors that were associated with the calcifications.
Methods:
Two hundred and fifty-nine adult chronic hemodialysis patients, 300 predialysis CKD patients and 60 healthy subjects with normal kidney function as a control group were enrolled in the study. Lateral lumbar radiography was used to measure AAC. Calcified deposits of the abdominal aorta wall at the level of the first through fourth lumbar vertebrae were graded by a 24-point scoring system.
Results:
AAC prevalence (AAC score ≥1) was significantly different in hemodialysis, predialysis and control groups (71.8, 45.7 and 33.3 %, respectively; p < 0.001). AAC prevalence in CKD stages 1, 2, 3, 4 and 5 predialysis patients was 26.6, 43.3, 40, 58.3 and 55 %, respectively. AAC scores of the hemodialysis group were higher than of the predialysis group (p < 0.001) and the control group (p < 0.001). AAC scores of the predialysis group were not higher than of the control group (p = 0.314). AAC scores of the hemodialysis group were significantly higher than of the control group (p < 0.001) and stage 1 (p < 0.001), stage 2 (p = 0.001) and stage 3 predialysis groups (p = 0.002). Age (p < 0.001), presence of diabetes mellitus (p < 0.001) and serum phosphorus levels (p = 0.011) were found to be independent predictors of calcification in the hemodialysis group. Age (p < 0.001), serum phosphorus levels (p = 0.007) and history of cardiovascular disease (p = 0.014) were found to be independent predictors of calcification in the predialysis group.
Conclusions:
Abdominal aortic calcification is highly prevalent in the hemodialysis population. Strict phosphorus control should be implemented to the predialysis and hemodialysis patients.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations

